Job/Unit: I30254
/KAP1
Date: 29-04-13 10:59:14
Pages: 6
FULL PAPER
Kinetic Measurements: The rates of the reaction between NO2Cbl
and glutathione (GSH) were determined under pseudo-first-order
conditions with excess GSH. Stock solutions of GSH (0.500 m) in
the presence or absence of sodium nitrite (5.00ϫ10–4 m) were pre-
pared in the appropriate buffer (0.020 m) at pH 4.00 and 7.00 and
diluted as appropriate. A small aliquot of concentrated NO2Cbl
(final concentration 5.0ϫ10–5 m) in water was added to initiate the
reaction, and the absorbance at 354 nm was recorded as a function
of time.
Kinetic data for the reaction between H2OCbl+ (5.0ϫ10–5 m) with
varying concentrations of NO2– were obtained at pH 4.00 and 7.00.
Stock solutions of NaNO2 (0.010 m) were prepared in the appropri-
ate buffer (0.020 m) and diluted as needed. Data were collected at
354 nm. Kinetic data for the reaction of H2OCbl+ (5.0ϫ10–5 m)
with varying concentrations of glutathione at pH 4.00 were col-
lected at 354 nm in acetate buffer (0.020 m).
The rate of decomposition of NO2Cbl to H2OCbl+ was determined
in the pH 3.5–6.0 range by adding solid NO2Cbl directly to the
appropriate buffer solution (0.200 m; the solution was thermostat-
ted at 25.0 °C for 10 min prior to the addition of NaNO2). The
solution was quickly filtered through a micropore filter (0.45 μm),
and data collection initiated at 354 nm.
The rate of decomposition of GSCbl to H2OCbl+ was determined
at pH 4.00. An aliquot of GSCbl (4.0ϫ10–5 m) was added to pH
4.00 acetate buffer (0.020 m; the buffer solution was thermostatted
at 25.0 °C for 10 min prior to the addition of GSCbl), and data
were collected at 354 nm.
in the pH 4–7 region. By independently determining values
of k1, k–1, k2, and k–2, we have shown that the data fits a
model involving an H2OCbl+ intermediate, which then
rapidly reacts with GSH to form GSCbl (Scheme 1). To our
knowledge, this is the first time that the reaction pathway
of β-axial inorganic ligand exchange for cob(III)alamins via
an H2OCbl+ intermediate has been unequivocally demon-
strated. This may have important consequences for free and
potentially for even protein-bound cob(III)alamins incor-
porating inorganic ligands (X-ray structures of cobalamins
bound to B12 transport proteins show that the β-axial site
can be readily accessed by solvent and small molecules[21]);
that is, the amount of each of these species may reflect the
concentrations and binding constants to aquacobalamin of
the various inorganic ligands present. As such, GSCbl
would be expected to be the major intracellular non-alkyl-
cob(III)alamin, given that intracellular GSH concentrations
are in the mm region,[14] and only CN– binds more strongly
than GSH to H2OCbl+ (KCNCbl ≈ 1014 –1[22]). Finally, at
m
0.5 mm GSH, the rate constant for the reaction between
NO2Cbl and GSH is ≈8ϫ10–3 s–1 at pH 7.0 (25 °C), which
corresponds to a half-life of about 1.4 min. Hence, forma-
tion of GSCbl is one possible reaction pathway by which
NO2Cbl decomposes in biological systems.
Experimental Section
The total ionic strength was maintained at 1.0 m by using
NaCF3SO3 for all solutions.
General: Hydroxycobalamin hydrochloride (HOCbl·HCl, 98%
stated purity by manufacturer) was purchased from Fluka. Gluta-
thione (98%), acetic acid (sodium salt, Ն 99%), sodium nitrite
(97%), and CF3SO3H (99%) were obtained from Acros Organics.
TES buffer (98%) was purchased from MP Biomedicals Inc. Potas-
sium dihydrogen phosphate was purchased from Sigma. NaCF3SO3
was prepared by neutralizing a concentrated, aqueous solution of
CF3SO3H with NaOH, by reducing it to dryness by rotary evapora-
tion, and by drying it overnight in a vacuum oven at 70.0 °C. Nitro-
cobalamin was synthesized and characterized according to a pub-
Supporting Information (see footnote on the first page of this arti-
cle): Further kinetic plots, UV/Vis spectra and rate constants are
presented.
Acknowledgments
This research was funded by the US National Science Foundation
(CHE-084839) and the US National Institute of General Medical
Sciences of the National Institutes of Health (1R15GM094707-
01A1). The content is solely the responsibility of the authors and
does not necessarily represent the official views of the National
Institutes of Health. Funding for this work was also provided by
the NSF-REU program at KSU [CHE-1004987 (D. W.) and CHE-
0649017 (K. G.)].
1
lished procedure.[15] The purity was Ն 95%, as determined by H
NMR spectroscopy.
UV/Vis spectra and kinetic data for slower reactions were recorded
on a Cary 5000 spectrophotometer equipped with a thermostatted
(25.0Ϯ0.1 °C) cell changer operating with WinUV Bio software
(version 3.00). Reactant solutions were thermostatted for 15 min
prior to measurements. Kinetic data for rapid reactions were ob-
tained at 25.0Ϯ0.1 °C by using an Applied Photophysics SX20
stopped-flow spectrophotometer equipped with a photodiode array
detector in addition to a single wavelength detector. Data were col-
lected with Pro-Data SX (version 2.1.4) and Pro-Data Viewer (ver-
sion 4.1.10) software, and a 1.0 cm pathlength cell was utilized. All
data were analyzed by using Microcal Origin version 8.0.
[1] a) B. Kräutler, S. Ostermann, The Porphyrin Handbook (Eds.:
K. M. Kadish, K. M. Smith, R. Guilard), Academic Press, San
Diego, 2003, ch. 68, p. 229; b) R. Banerjee (Ed.), Chemistry
and Biochemistry of B12, Wiley & Sons, New York, 1999; c)
K. L. Brown, Chem. Rev. 2005, 105, 2075.
[2] a) G. Scalabrino, E. Mutti, D. Veber, L. Aloe, M. M. Corsi,
S. Galbiati, G. Tredici, Neurosci. Lett. 2006, 396, 153; b) G.
Scalabrino, M. Peracchi, Trends Mol. Med. 2006, 12, 247; c)
D. Veber, E. Mutti, L. Tacchini, E. Gammella, G. Tredici, G.
Scalabrino, J. Neurosci. Res. 2008, 86, 1380–1387; d) R. Mukh-
erjee, N. E. Brasch, Chem. Eur. J. 2011, 17, 11673; e) C. S.
Birch, N. E. Brasch, A. McCaddon, J. H. H. Williams, Free
Radical Biol. Med. 2009, 47, 184; f) E. S. Moreira, N. E.
Brasch, J. Yun, Free Radical Biol. Med. 2011, 51, 876; g) E.
Suarez-Moreira, J. Yun, C. S. Birch, J. H. H. Williams, A.
McCaddon, N. E. Brasch, J. Am. Chem. Soc. 2009, 131, 15078.
[3] a) L. Ignarro, J. Cardiovasc. Pharmacol. 1999, 34, 879; b) J.
Heinecke, P. C. Ford, Coord. Chem. Rev. 2010, 254, 235; c)
A. A. Avery, Environ. Health Perspect. 1999, 107, 583.
pH measurements were carried out by using an Orion model 710A
pH meter equipped with a Wilmad 6030–02 pH electrode. The elec-
trode was filled with a 3 m KCl/saturated AgCl solution (pH 7.0)
and standardized with standard BDH buffer solutions at pH 6.98,
4.01, and 2.02. Solution pH was adjusted by using 50% v/v aque-
ous CF3SO3H and NaOH (≈5 m).
1H NMR spectra was recorded on a Bruker Avance 400 MHz spec-
trometer equipped with 5 mm probe. Solutions for NMR measure-
1
ments were prepared in D2O. H NMR spectra were internally ref-
erenced to TSP (δ =0 ppm).
Eur. J. Inorg. Chem. 0000, 0–0
5
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim